SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Clinical trial NCT00006013 · COMPLETED

Trial details

NCT number: NCT00006013
Sponsor: Fox Chase Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2000-06-01
Primary completion: 2003-01-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.